Biotech firm Dyne Therapeutics nabs $50 mln Series A

Cambridge, Massachusetts-based Dyne Therapeutics, a new biotechnology company, has secured $50 million in Series A funding. The investors were Atlas Venture, Forbion and MPM Capital.

Source: Press Release